Dopamine neuron transplant: breakthrough in Parkinson's treatment

After decades of research, scientists have launched the first clinical trials of dopamine neuron transplants in Parkinson's patients. The disease destroys these nerve cells, causing gradual loss of movement control. Early therapy results show promising effects, published in Nature on November 4, 2026.